Distribution Evaluation of Tenofovir in the Breast Milk of Mothers With HBeAg-Positive Chronic HBV Infection After Treatment With Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate by a Sensitive UPLC-MS/MS Method

• मुख्य लेखकों: Na Yang (लेखक), Guanlun Zhou (लेखक), Xiaoliang Cheng (लेखक), Jun He (लेखक), Yan Chen (लेखक), Chao Chen (लेखक), Meijuan Li (लेखक), Jiajia Ge (लेखक), Min Wang (लेखक), Tianqi Zhang (लेखक), Weihong Ge (लेखक), Huaijun Zhu (लेखक), Guorong Han (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2021-08-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Tenofovir alafenamide (TAF) is a novel prodrug of tenofovir (TFV) that has been approved for the treatment of chronic hepatitis B virus (HBV) infection. It has greater plasma stability and more favorable renal safety than tenofovir disoproxil fumarate (TDF), the first approved oral prodrug of TFV. H...